家庭用インスリンデリバリー(投与)機器の世界市場成長率 2022-2028Global Home Insulin Delivery (Dosing) Devices Market Growth 2022-2028 世界経済の回復に伴い、家庭用インスリンデリバリー(投与)装置の2021年の成長は、前年から大きな変化を遂げるでしょう。弊社(LP Information)の最新調査によると、家庭用インスリンデリバリー(投与)装置の... もっと見る
サマリー世界経済の回復に伴い、家庭用インスリンデリバリー(投与)装置の2021年の成長は、前年から大きな変化を遂げるでしょう。弊社(LP Information)の最新調査によると、家庭用インスリンデリバリー(投与)装置の世界市場規模は2021年の100万米ドルから2022年には100万米ドルとなり、2021年と2022年の間に%変化します。世界の家庭用インスリンデリバリー(投与)機器の市場規模は、2028年には百万米ドルに達し、分析期間2022年から2028年にかけて年平均成長率(%)で成長すると予測されます。米国の家庭用インスリンデリバリー(投与)装置市場は、2021年に百万米ドルの価値があり、予測期間2022-2028年に約%のCAGRで成長すると予想されます。中国は、世界の家庭用インスリンデリバリー(投与)デバイス市場の % 市場を構成し、2028年までに100万米ドルに達します。ヨーロッパでは、ドイツが2028年までに100万ドルに達し、2022年から2028年の予測期間中にCAGRが%になると予測されています。APACでは、他の注目すべき市場(日本、韓国)の成長率は、今後6年間、それぞれ%と%と予測されています。 世界の主な家庭用インスリンデリバリー(投与)機器メーカーは、Tandem Diabetes Care、Biocon、Roche Holding AG、Insulet Corporationなどです。収益面では、世界の上位2社が2021年にほぼ%のシェアを占めています。 本レポートでは、家庭用インスリン送達(投与)装置市場の包括的な概要、市場シェア、成長機会を、製品タイプ、アプリケーション、主要メーカー、主要地域、国別に紹介します。 タイプ別区分:2.3項では2017年から2022年までの内訳データ、12.6項では2028年までの予測データ インスリンペン インスリンポンプ インスリン注射器 その他 用途別セグメント:2017年から2022年までの内訳データは2.4項、2028年までの予測は12.7項。 病院薬局 オンライン薬局 小売薬局 また、本レポートでは、地域別に市場を分割しています。第4章、第5章、第6章、第7章、第8章における内訳データ。 米州 米国 カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア 欧州 ドイツ フランス イギリス イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 また、本レポートでは、市場の競争環境と、それに対応する本市場の著名メーカーの詳細な分析も紹介しています。 タンデムダイアベッツケア バイオコン ロシュ・ホールディングAG インスレット社 B. ブラウン BD イーライリリー・アンド・カンパニー ノボ ノルディスク サノフィ ウォックハート イプソメドホールディング メドトロニック ジュルファル ベータ・バイオニクス コペルニクス ダンスバイオファーム デビオテック マンカインド オーウェン マンフォード ソイル バレリータ ウエストファーマ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Country/Region, 2017, 2022 & 2028 2.2 Home Insulin Delivery (Dosing) Devices Segment by Type 2.2.1 Insulin Pens 2.2.2 Insulin Pumps 2.2.3 Insulin Syringes 2.2.4 Others 2.3 Home Insulin Delivery (Dosing) Devices Sales by Type 2.3.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022) 2.3.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Type (2017-2022) 2.3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Type (2017-2022) 2.4 Home Insulin Delivery (Dosing) Devices Segment by Application 2.4.1 Hospitals Pharmacy 2.4.2 Online Pharmacy 2.4.3 Retail Pharmacy 2.5 Home Insulin Delivery (Dosing) Devices Sales by Application 2.5.1 Global Home Insulin Delivery (Dosing) Devices Sale Market Share by Application (2017-2022) 2.5.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Application (2017-2022) 2.5.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Application (2017-2022) 3 Global Home Insulin Delivery (Dosing) Devices by Company 3.1 Global Home Insulin Delivery (Dosing) Devices Breakdown Data by Company 3.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Company (2020-2022) 3.1.2 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Company (2020-2022) 3.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Company (2020-2022) 3.2.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Company (2020-2022) 3.2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Company (2020-2022) 3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Company 3.4 Key Manufacturers Home Insulin Delivery (Dosing) Devices Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Home Insulin Delivery (Dosing) Devices Product Location Distribution 3.4.2 Players Home Insulin Delivery (Dosing) Devices Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Home Insulin Delivery (Dosing) Devices by Geographic Region 4.1 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Geographic Region (2017-2022) 4.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Geographic Region 4.2 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Country/Region (2017-2022) 4.2.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Country/Region (2017-2022) 4.2.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Country/Region 4.3 Americas Home Insulin Delivery (Dosing) Devices Sales Growth 4.4 APAC Home Insulin Delivery (Dosing) Devices Sales Growth 4.5 Europe Home Insulin Delivery (Dosing) Devices Sales Growth 4.6 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Growth 5 Americas 5.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country 5.1.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) 5.1.2 Americas Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) 5.2 Americas Home Insulin Delivery (Dosing) Devices Sales by Type 5.3 Americas Home Insulin Delivery (Dosing) Devices Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region 6.1.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022) 6.1.2 APAC Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022) 6.2 APAC Home Insulin Delivery (Dosing) Devices Sales by Type 6.3 APAC Home Insulin Delivery (Dosing) Devices Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Home Insulin Delivery (Dosing) Devices by Country 7.1.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) 7.1.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) 7.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Type 7.3 Europe Home Insulin Delivery (Dosing) Devices Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices by Country 8.1.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) 8.1.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) 8.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Type 8.3 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Home Insulin Delivery (Dosing) Devices 10.3 Manufacturing Process Analysis of Home Insulin Delivery (Dosing) Devices 10.4 Industry Chain Structure of Home Insulin Delivery (Dosing) Devices 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Home Insulin Delivery (Dosing) Devices Distributors 11.3 Home Insulin Delivery (Dosing) Devices Customer 12 World Forecast Review for Home Insulin Delivery (Dosing) Devices by Geographic Region 12.1 Global Home Insulin Delivery (Dosing) Devices Market Size Forecast by Region 12.1.1 Global Home Insulin Delivery (Dosing) Devices Forecast by Region (2023-2028) 12.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Home Insulin Delivery (Dosing) Devices Forecast by Type 12.7 Global Home Insulin Delivery (Dosing) Devices Forecast by Application 13 Key Players Analysis 13.1 Tandem Diabetes Care 13.1.1 Tandem Diabetes Care Company Information 13.1.2 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Offered 13.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Tandem Diabetes Care Main Business Overview 13.1.5 Tandem Diabetes Care Latest Developments 13.2 Biocon 13.2.1 Biocon Company Information 13.2.2 Biocon Home Insulin Delivery (Dosing) Devices Product Offered 13.2.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Biocon Main Business Overview 13.2.5 Biocon Latest Developments 13.3 Roche Holding AG 13.3.1 Roche Holding AG Company Information 13.3.2 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Offered 13.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Roche Holding AG Main Business Overview 13.3.5 Roche Holding AG Latest Developments 13.4 Insulet Corporation 13.4.1 Insulet Corporation Company Information 13.4.2 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Offered 13.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Insulet Corporation Main Business Overview 13.4.5 Insulet Corporation Latest Developments 13.5 B. Braun 13.5.1 B. Braun Company Information 13.5.2 B. Braun Home Insulin Delivery (Dosing) Devices Product Offered 13.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 B. Braun Main Business Overview 13.5.5 B. Braun Latest Developments 13.6 BD 13.6.1 BD Company Information 13.6.2 BD Home Insulin Delivery (Dosing) Devices Product Offered 13.6.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 BD Main Business Overview 13.6.5 BD Latest Developments 13.7 Eli Lilly and Company 13.7.1 Eli Lilly and Company Company Information 13.7.2 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Offered 13.7.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 Eli Lilly and Company Main Business Overview 13.7.5 Eli Lilly and Company Latest Developments 13.8 Novo Nordisk 13.8.1 Novo Nordisk Company Information 13.8.2 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Offered 13.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 Novo Nordisk Main Business Overview 13.8.5 Novo Nordisk Latest Developments 13.9 Sanofi 13.9.1 Sanofi Company Information 13.9.2 Sanofi Home Insulin Delivery (Dosing) Devices Product Offered 13.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 Sanofi Main Business Overview 13.9.5 Sanofi Latest Developments 13.10 Wockhardt 13.10.1 Wockhardt Company Information 13.10.2 Wockhardt Home Insulin Delivery (Dosing) Devices Product Offered 13.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 Wockhardt Main Business Overview 13.10.5 Wockhardt Latest Developments 13.11 Ypsomed Holding 13.11.1 Ypsomed Holding Company Information 13.11.2 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Offered 13.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 Ypsomed Holding Main Business Overview 13.11.5 Ypsomed Holding Latest Developments 13.12 Medtronic 13.12.1 Medtronic Company Information 13.12.2 Medtronic Home Insulin Delivery (Dosing) Devices Product Offered 13.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.12.4 Medtronic Main Business Overview 13.12.5 Medtronic Latest Developments 13.13 Julphar 13.13.1 Julphar Company Information 13.13.2 Julphar Home Insulin Delivery (Dosing) Devices Product Offered 13.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.13.4 Julphar Main Business Overview 13.13.5 Julphar Latest Developments 13.14 Beta Bionics 13.14.1 Beta Bionics Company Information 13.14.2 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Offered 13.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.14.4 Beta Bionics Main Business Overview 13.14.5 Beta Bionics Latest Developments 13.15 Copernicus 13.15.1 Copernicus Company Information 13.15.2 Copernicus Home Insulin Delivery (Dosing) Devices Product Offered 13.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.15.4 Copernicus Main Business Overview 13.15.5 Copernicus Latest Developments 13.16 Dance Biopharm 13.16.1 Dance Biopharm Company Information 13.16.2 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Offered 13.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.16.4 Dance Biopharm Main Business Overview 13.16.5 Dance Biopharm Latest Developments 13.17 Debiotech 13.17.1 Debiotech Company Information 13.17.2 Debiotech Home Insulin Delivery (Dosing) Devices Product Offered 13.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.17.4 Debiotech Main Business Overview 13.17.5 Debiotech Latest Developments 13.18 MannKind 13.18.1 MannKind Company Information 13.18.2 MannKind Home Insulin Delivery (Dosing) Devices Product Offered 13.18.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.18.4 MannKind Main Business Overview 13.18.5 MannKind Latest Developments 13.19 Owen Mumford 13.19.1 Owen Mumford Company Information 13.19.2 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Offered 13.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.19.4 Owen Mumford Main Business Overview 13.19.5 Owen Mumford Latest Developments 13.20 SOOIL 13.20.1 SOOIL Company Information 13.20.2 SOOIL Home Insulin Delivery (Dosing) Devices Product Offered 13.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.20.4 SOOIL Main Business Overview 13.20.5 SOOIL Latest Developments 13.21 Valeritas 13.21.1 Valeritas Company Information 13.21.2 Valeritas Home Insulin Delivery (Dosing) Devices Product Offered 13.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.21.4 Valeritas Main Business Overview 13.21.5 Valeritas Latest Developments 13.22 West Pharma 13.22.1 West Pharma Company Information 13.22.2 West Pharma Home Insulin Delivery (Dosing) Devices Product Offered 13.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.22.4 West Pharma Main Business Overview 13.22.5 West Pharma Latest Developments 14 Research Findings and Conclusion
SummaryAs the global economy mends, the 2021 growth of Home Insulin Delivery (Dosing) Devices will have significant change from previous year. According to our (LP Information) latest study, the global Home Insulin Delivery (Dosing) Devices market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Home Insulin Delivery (Dosing) Devices market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Country/Region, 2017, 2022 & 2028 2.2 Home Insulin Delivery (Dosing) Devices Segment by Type 2.2.1 Insulin Pens 2.2.2 Insulin Pumps 2.2.3 Insulin Syringes 2.2.4 Others 2.3 Home Insulin Delivery (Dosing) Devices Sales by Type 2.3.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022) 2.3.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Type (2017-2022) 2.3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Type (2017-2022) 2.4 Home Insulin Delivery (Dosing) Devices Segment by Application 2.4.1 Hospitals Pharmacy 2.4.2 Online Pharmacy 2.4.3 Retail Pharmacy 2.5 Home Insulin Delivery (Dosing) Devices Sales by Application 2.5.1 Global Home Insulin Delivery (Dosing) Devices Sale Market Share by Application (2017-2022) 2.5.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Application (2017-2022) 2.5.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Application (2017-2022) 3 Global Home Insulin Delivery (Dosing) Devices by Company 3.1 Global Home Insulin Delivery (Dosing) Devices Breakdown Data by Company 3.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Company (2020-2022) 3.1.2 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Company (2020-2022) 3.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Company (2020-2022) 3.2.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Company (2020-2022) 3.2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Company (2020-2022) 3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Company 3.4 Key Manufacturers Home Insulin Delivery (Dosing) Devices Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Home Insulin Delivery (Dosing) Devices Product Location Distribution 3.4.2 Players Home Insulin Delivery (Dosing) Devices Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Home Insulin Delivery (Dosing) Devices by Geographic Region 4.1 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Geographic Region (2017-2022) 4.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Geographic Region 4.2 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Country/Region (2017-2022) 4.2.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Country/Region (2017-2022) 4.2.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Country/Region 4.3 Americas Home Insulin Delivery (Dosing) Devices Sales Growth 4.4 APAC Home Insulin Delivery (Dosing) Devices Sales Growth 4.5 Europe Home Insulin Delivery (Dosing) Devices Sales Growth 4.6 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Growth 5 Americas 5.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country 5.1.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) 5.1.2 Americas Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) 5.2 Americas Home Insulin Delivery (Dosing) Devices Sales by Type 5.3 Americas Home Insulin Delivery (Dosing) Devices Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region 6.1.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022) 6.1.2 APAC Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022) 6.2 APAC Home Insulin Delivery (Dosing) Devices Sales by Type 6.3 APAC Home Insulin Delivery (Dosing) Devices Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Home Insulin Delivery (Dosing) Devices by Country 7.1.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) 7.1.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) 7.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Type 7.3 Europe Home Insulin Delivery (Dosing) Devices Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices by Country 8.1.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) 8.1.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) 8.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Type 8.3 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Home Insulin Delivery (Dosing) Devices 10.3 Manufacturing Process Analysis of Home Insulin Delivery (Dosing) Devices 10.4 Industry Chain Structure of Home Insulin Delivery (Dosing) Devices 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Home Insulin Delivery (Dosing) Devices Distributors 11.3 Home Insulin Delivery (Dosing) Devices Customer 12 World Forecast Review for Home Insulin Delivery (Dosing) Devices by Geographic Region 12.1 Global Home Insulin Delivery (Dosing) Devices Market Size Forecast by Region 12.1.1 Global Home Insulin Delivery (Dosing) Devices Forecast by Region (2023-2028) 12.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Home Insulin Delivery (Dosing) Devices Forecast by Type 12.7 Global Home Insulin Delivery (Dosing) Devices Forecast by Application 13 Key Players Analysis 13.1 Tandem Diabetes Care 13.1.1 Tandem Diabetes Care Company Information 13.1.2 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Offered 13.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Tandem Diabetes Care Main Business Overview 13.1.5 Tandem Diabetes Care Latest Developments 13.2 Biocon 13.2.1 Biocon Company Information 13.2.2 Biocon Home Insulin Delivery (Dosing) Devices Product Offered 13.2.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Biocon Main Business Overview 13.2.5 Biocon Latest Developments 13.3 Roche Holding AG 13.3.1 Roche Holding AG Company Information 13.3.2 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Offered 13.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Roche Holding AG Main Business Overview 13.3.5 Roche Holding AG Latest Developments 13.4 Insulet Corporation 13.4.1 Insulet Corporation Company Information 13.4.2 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Offered 13.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Insulet Corporation Main Business Overview 13.4.5 Insulet Corporation Latest Developments 13.5 B. Braun 13.5.1 B. Braun Company Information 13.5.2 B. Braun Home Insulin Delivery (Dosing) Devices Product Offered 13.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 B. Braun Main Business Overview 13.5.5 B. Braun Latest Developments 13.6 BD 13.6.1 BD Company Information 13.6.2 BD Home Insulin Delivery (Dosing) Devices Product Offered 13.6.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 BD Main Business Overview 13.6.5 BD Latest Developments 13.7 Eli Lilly and Company 13.7.1 Eli Lilly and Company Company Information 13.7.2 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Offered 13.7.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 Eli Lilly and Company Main Business Overview 13.7.5 Eli Lilly and Company Latest Developments 13.8 Novo Nordisk 13.8.1 Novo Nordisk Company Information 13.8.2 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Offered 13.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 Novo Nordisk Main Business Overview 13.8.5 Novo Nordisk Latest Developments 13.9 Sanofi 13.9.1 Sanofi Company Information 13.9.2 Sanofi Home Insulin Delivery (Dosing) Devices Product Offered 13.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 Sanofi Main Business Overview 13.9.5 Sanofi Latest Developments 13.10 Wockhardt 13.10.1 Wockhardt Company Information 13.10.2 Wockhardt Home Insulin Delivery (Dosing) Devices Product Offered 13.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 Wockhardt Main Business Overview 13.10.5 Wockhardt Latest Developments 13.11 Ypsomed Holding 13.11.1 Ypsomed Holding Company Information 13.11.2 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Offered 13.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 Ypsomed Holding Main Business Overview 13.11.5 Ypsomed Holding Latest Developments 13.12 Medtronic 13.12.1 Medtronic Company Information 13.12.2 Medtronic Home Insulin Delivery (Dosing) Devices Product Offered 13.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.12.4 Medtronic Main Business Overview 13.12.5 Medtronic Latest Developments 13.13 Julphar 13.13.1 Julphar Company Information 13.13.2 Julphar Home Insulin Delivery (Dosing) Devices Product Offered 13.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.13.4 Julphar Main Business Overview 13.13.5 Julphar Latest Developments 13.14 Beta Bionics 13.14.1 Beta Bionics Company Information 13.14.2 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Offered 13.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.14.4 Beta Bionics Main Business Overview 13.14.5 Beta Bionics Latest Developments 13.15 Copernicus 13.15.1 Copernicus Company Information 13.15.2 Copernicus Home Insulin Delivery (Dosing) Devices Product Offered 13.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.15.4 Copernicus Main Business Overview 13.15.5 Copernicus Latest Developments 13.16 Dance Biopharm 13.16.1 Dance Biopharm Company Information 13.16.2 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Offered 13.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.16.4 Dance Biopharm Main Business Overview 13.16.5 Dance Biopharm Latest Developments 13.17 Debiotech 13.17.1 Debiotech Company Information 13.17.2 Debiotech Home Insulin Delivery (Dosing) Devices Product Offered 13.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.17.4 Debiotech Main Business Overview 13.17.5 Debiotech Latest Developments 13.18 MannKind 13.18.1 MannKind Company Information 13.18.2 MannKind Home Insulin Delivery (Dosing) Devices Product Offered 13.18.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.18.4 MannKind Main Business Overview 13.18.5 MannKind Latest Developments 13.19 Owen Mumford 13.19.1 Owen Mumford Company Information 13.19.2 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Offered 13.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.19.4 Owen Mumford Main Business Overview 13.19.5 Owen Mumford Latest Developments 13.20 SOOIL 13.20.1 SOOIL Company Information 13.20.2 SOOIL Home Insulin Delivery (Dosing) Devices Product Offered 13.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.20.4 SOOIL Main Business Overview 13.20.5 SOOIL Latest Developments 13.21 Valeritas 13.21.1 Valeritas Company Information 13.21.2 Valeritas Home Insulin Delivery (Dosing) Devices Product Offered 13.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.21.4 Valeritas Main Business Overview 13.21.5 Valeritas Latest Developments 13.22 West Pharma 13.22.1 West Pharma Company Information 13.22.2 West Pharma Home Insulin Delivery (Dosing) Devices Product Offered 13.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022) 13.22.4 West Pharma Main Business Overview 13.22.5 West Pharma Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(電子部品/半導体)の最新刊レポート
LP Information社のその他分野での最新刊レポート
本レポートと同じKEY WORD(home)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/20 10:28 158.95 円 165.20 円 201.28 円 |